When oncology practices participate in clinical trials, it is a win-win situation. Patients get the chance to experience innovative treatments that are already being tested but have not yet been approved. Physicians develop knowledge about treatments and procedures at the cutting edge of research. CROs and sponsors benefit from a faster trials start-up and higher patient retention due to the increased patient base of practicing oncologists. How does this play out in practice?
